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Abstract 
Purpose: To construct a cluster model or a gene signature for Stevens-Johnson syndrome (SJS) using 
pathways analysis in order to identify some potential biomarkers that may be used for early detection of 
SJS and epidermal necrolysis (TEN) manifestations. 
Methods: Gene expression profiles of GSE12829 were downloaded from Gene Expression Omnibus 
database. A total of 193 differentially expressed genes (DEGs) were obtained. We applied these genes 
to geneMANIA database, to remove ambiguous and duplicated genes, and after that, characterized the 
gene expression profiles using geneMANIA, DAVID, REACTOME, STRING and GENECODIS which 
are online software and databases. 
Results: Out of 193 genes, only 91 were used (after removing the ambiguous and duplicated genes) for 
topological analysis. It was found by geneMANIA database search that majority of these genes were co-
expressed yielding 84.63 % co-expression. It was found that ten genes were in Physical interactions 
comprising almost 14.33 %. There were < 1 % pathway and genetic interactions with values of 0.97 and 
0.06 %, respectively. Final analyses revealed that there are two clusters of gene interactions and 13 
genes were shown to be in evident relationship of interaction with regards to hypersensitivity. 
Conclusion: Analysis of differential gene expressions by topological and database approaches in the 
current study reveals 2 gene network clusters. These genes are CD3G, CD3E, CD3D, TK1, TOP2A, 
CDK1, CDKN3, CCNB1, and CCNF. There are 9 key protein interactions in hypersensitivity reactions 
and may serve as biomarkers for SJS and TEN. Pathways related gene clusters has been identified and 
a genetic model to predict SJS and TEN early incidence using these biomarker genes has been 
developed.  
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Stevens-Johnson syndrome (SJS) and toxic 
epidermal necrolysis (TEN) are severe and rare 
cutaneous adverse reactions (SCAR) 
manifestations. It is believed that they are 
caused by certain drugs which may consequently 
lead to significant morbidity and mortality 
worldwide [1]. Although, effects of such 
manifestations are not localized, yet skin is the 
vulnerable tissue for such reactions. SJS and 
TEN are considered the most serious and fatal 
skin diseases among cutaneous drug-induced 
hypersensitivity adverse reactions [2]. SJS and 
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TEN are immune mediated hypersensitivity 
reactions that involve the skin and mucous 
membranes. They are distinguished by bullous 
formation followed by epidermal detachment that 
eventually affects mucous membranes [3]. 
Currently, more than 5 % of the patients with SJS 
and 30 % of the patients with TEN die [4]. 
However, the underlying mechanism leading to 
such death have not been discovered yet. 
 
T-cell pathways involvement was reported to be 
associated with TEN reaction over a decade ago, 
in addition to the recently reported Granulysin 
and natural killer cells inhibitory receptors [5-7]. 
Although these mechanisms were useful to 
decipher some of the largely unknown 
mechanisms underlying such a complex disease, 
yet there must be further predictors and 
biomarkers on the genetic level. Moreover, 
various studies have shown that several 
cytokines might play role in the apoptosis or the 
cytokine inflammations in SJS and TEN. Among 
these recently discovered cytokines are the 
interleukin (IL) IL-6, IL-8 and monocyte chemo-
attractant protein-1 (MCP-1). All of these were 
upregulated in such manifestations [8].These 
cytokines and others are important cellular 
regulators and mobilizers of cells engaged in 
innate as well as adaptive inflammatory immunity 
which has interlocking factors to both SJS and 
TEN [9,10]. Cytokines are released by various 
cells in the body, usually in response to an 
activating stimulus, and they induce responses 
by binding to specific receptors on the surface of 
target cells [11]. Levels of pro-inflammatory 
cytokines were significantly higher in SJS and 
TEN patient samples than the healthy controls 
[12]. 
 
Main objective of the study is to establish 
relevant biomarkers for SJS and TEN early 
detection using the genetic mapping of DEG SJS 
and TEN patients’ samples. Protein-protein 
interaction network and pathways analysis tools 
along with other online databases and software 
not only provide information about these specific 
DEG proteins in severe cutaneous adverse 
reaction, but also pave the path towards 





Gene set array 
 
Gene expression profiles of GSE12829 were 
downloaded from Gene Expression Omnibus 
(GEO) database that has been investigated 
previously by Bellon et al [13]. The samples of 
twenty three patients suffering from cutaneous 
drug-induced hypersensitivity reactions were 
matched to eight healthy controls who were 
using the same medications.  A total of 193 
genes were found with distinct expressions in 
comparison between healthy controls and 
patients samples. GEO2R technique [14], (which 
is already available on Gene Expression 
Omnibus) was used to acquire the relevant gene 
list. Thereafter, these genes were loaded to 
geneMANIA database [15] to remove ambiguous 
and duplicate genes. 
 
Database search  
 
Gene expression profiles were characterized 
using DAVID (Database for Annotation, 
Visualization and Integrated Discovery). DAVID 
web tool provides a comprehensive set of 
functional annotation tools for researchers to 
understand biological meaning behind large list 
of genes [16]. In this study, the DAVID tool was 
used to annotate the function of our genes list. It 
lead to the selection of the Gene Ontology (GO) 
terms with adjusted p-value less than 0.05 and 
count larger than 5. 
 
The STRING (Search Tool for the Retrieval of 
Interacting Genes) version 9.1 [17], database 
provides both experimental and predicted 
interaction information. Version 9.1 of STRING 
covers more than 1100 completely sequenced 
organisms. To identify the interactive 
relationships among target genes or other genes, 
genes list was mapped to STRING. GeneMANIA 
was again used to figure out genes that have 
protein and genetic interactions, pathways, co-
expression, or co-localization [15]. It was also 
utilized to generate the relevant network with 
different scores. 
 
The genes were then analyzed and 
characterized in KEGG (Kyoto Encyclopedia of 
Genes and Genomes) pathway categories [18] 
by the GENECODIS software [19]. REACTOME 
is a bioinformatics tool for the visualization, 
interpretation and analysis of pathway knowledge 
to support basic research, genome analysis, 




GeneMANIA analysis yielded 9-core nodes 
genes network 
 
In this study, multiple databases approaches has 
been used to identify the pathways and network 
trends for the produced gene list. Primarily, 
majority of these genes were co-expressed 
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together 84.63 % co-expression, and 14.33 % 
were in physical interaction. GeneMANIA 
database [15] search yielded only < 1% for the 
pathway and genetic interactions with values of 
0.97 % and 0.06 %, respectively. The 9 nodes 
gene network was generated by GeneMania tool 
[15], as shown in Figure 1. 
 
Main protein-protein interaction networks 
generated by string (search tool for retrieval 
of interacting genes) version 9.1 [17]  
 
The protein-protein interaction network for our 
gene list, was identified using STRING (Search 
Tool for Retrieval of Interacting Genes) version 
9.1 [17]. The result was a generic multiple 
interacting proteins network, as shown in Figure 
2. 
 
After further analysis nine genes with two cluster 
networks (where most of interacting protein in 
SJS and TEN present) were focused, and those 
interacting proteins sub-network (clusters) are 
shown in Figure 3. 
 
REACTOME pathways analysis results 
showed 13 gene clusters mainly in immune 
and signaling pathways 
 
A set of 92 gene was applied to REACTOME 
pathways database [20]. The results reveal a 13-
gene cluster that showed that the major 
pathways were related to immune system 54 (4 
%), signal transduction 76 (4 %) and disease 
pathways 52 (5%). 
 
DAVID; database for annotation, visualization 
and integrated discovery result is agreeing 
with REACTOME database 
 
DAVID tool [16] results were also in accordance 
with the previous REACTOME output. Previous 
reports have shown T-cell mediated biological 
processes. DAVID results for the 13 gene were 
all targeting T-cell namely alpha-beta T-cell 
receptor complex, T-cell receptor complex, T-cell 




         
         Figure 1: GeneMania primary 9 gene network, black circles indicate the 9 genes core genes 
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Figure 2: Resulting protein-protein interaction main networks using String 9.1 Web software 
 
 
Figure 3: Nine genes which are the core evidence/confidence sub network obtained from STING web tool. It 
includes: CD3G, CD3E, CD3D, TK1, TOP2A, CDK1, CDKN3, CCNB1 and CCNF 
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Figure 4: Gene characterization results in the GENECODIS and KEGG pathways tools; ten significantly enriched 
signaling pathways are shown in descending order of the number of genes contained in each pathway 
 
Protein-protein interaction mainly 
participated in the biological processes 
which are related with immune system 
 
GENECODIS software yielded condensed ten 
signaling pathways mainly in immune system 
 
The genes were then analyzed and 
characterized by the GENECODIS program [19]. 
Ten significantly enriched signaling pathways are 
shown in descending order of the number of 
genes contained in each pathway, as explained 
in Figure 4. 
 
Kyoto encyclopedia of genes and genomes 
(KEGG) pathway analysis gave two main 
modules consisting of cytokine-cytokine 
receptor and T-cell receptor pathways 
 
The results of KEGG pathway enrichment 
analysis revealed that most of the genes in 2 
modules exist in cytokine-cytokine receptor 
interaction and T cell receptor signaling pathway. 
Please refer to supplementary data S5 for further 
clarification. 
 
Most of these DEG genes were found to be 
differentially expressed during the early phase of 
cutaneous drug-induced delayed hypersensitivity 
reactions. Furthermore, 9 genes were identified 
with distinct cluster expression and interaction 




This study have shown that specific gene cluster 
can be used not only for detection of  early 
incidence of SJS and TEN but also to predict 
clinical prognosis in the same disease setting. 
Genes and pathways that were associated with 
incidence of SJS and TEN have been identified 
via this research. Moreover, it has also been 
identified that 9 genes signature in SJS and TEN 
which include: CD3G, CD3E, CD3D, TK1, 
TOP2A, CDK1, CDKN3, CCNB1, and CCNF. 
The full name of gene as follows: CD3G, T-cell 
surface glycoprotein CD3 gamma chain. CD3E, 
CD3e molecule, epsilon. CD3D, T-cell surface 
glycoprotein CD3 delta chain. TK1, Thymidine 
kinase 1. TOP2A, DNA topoisomerase 2-alpha. 
CDK1, Cyclin-dependent kinase 1. CDKN3, 
Cyclin-dependent kinase inhibitor 3. CCNB1, 
G2/mitotic-specific cyclin-B1. CCNF, G2/mitotic-
specific cyclin-F. 
 
Up till now, the pathogenesis of SJS/TEN is yet 
to be fully elucidated. STS and TEN are complex 
disease forms and could cause certain fatalities. 
The current study has deployed many online 
research engines and databases to analyze the 
differentially expressed genes in these clinical 
manifestations.  geneMANIA results show that 
many of the inquired genes were ambiguous. 
However, the majority of these genes have 
evident role in immune and hypersensitivity 
reaction mechanisms [21]. Genes pathways in 
cytokine-cytokine receptor interaction and T-cell 
signaling shown by KEGG pathway analysis 
proved that these clusters are directly linked to 
SJS and TEN disease[18], and then the same 
has been confirmed via GENECODIS web tool 
as well [19]. Ten genes showing significantly 
enriched signaling pathways are shown in 
descending order of the number of genes 
contained in each pathway. 
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The first candidate pathway was cytokine-
cytokine receptor interaction which has been 
validated in many reports to be associated with 
SJS and TEN manifestations. Previously 
published studies have shown that several 
cytokines might play an important role in the 
apoptosis or cytokine flooded inflammation 
[8,22,23]. Among these recently discovered 
cytokines are the interleukin (IL), IL-6, IL-8 and 
monocyte chemo-attractant protein-1 (MCP-1) 
and all were reported to be unregulated in SJS 
and TEN [8]. 
 
Cytokine-cytokine receptor interaction is the most 
significant pathway in KEGG and GENCODIS 
analysis. It is not unusual to find cytokines in SJS 
and TEN as they are crucial cellular regulators 
and mobilizers of cells engaged in innate as well 
as adaptive inflammatory host defense, cell 
growth, and differentiation aimed at the 
restoration of homeostasis. Cytokines are 
released by various cells in the body in response 
to an activating stimulus, and they induce 
response by binding to specific receptors on the 
surface of target cells in case of immunological 
response as well as in SJS and TEN disease 
pathophysiology [24].  
 
Previous report by Miyagawa et al [25] state that 
expression pattern with lower expression of 
genes coding T cell-specific proteins and high 
expression of cell cycle-related genes and genes 
encoding for inflammatory related mediators 
have been shown [13]. 
 
This study extracted the gene set from Bellon et 
al which has been previously reported as well 
[13]. The drugs that cause the SJS were 
Clindamycin®, Spiramycin®, Statin, Phenytoin® 
and Allopurinol® [13]. These were the trigger of 
SJS manifestation and from where this gene 
expressions data come from. Meanwhile, 
Carbamazepine, furosemide, Erythromycin and 
paracetamol were more associated with TEN 
patients in the same cohort [13]. However, there 
are many other drugs that have shown 
substantial effects towards provoking SJS and 
TEN clinical reactions. For instance, in a study 
conducted by Barvaliya et al [26] it was found 
that antimicrobials were 50 % associated with 
these kind of reactions. NSAID’s and anti-seizure 
drugs were also associated and caused 22.41 % 
and 18.96 % of SJS and TEN cases respectively. 
According to the mentioned study Nevirapine 
was the most common drug in this regards which 
had an association of 28.12 %. They also figured 
out that anti-seizure drugs are mostly associated 
with such kind of adverse reactions. 
 
Earlier data reports confirm that Han-Chinese 
subjects who have the HLA-B*1502 allele are 
highly prone to high risk of SJS and TEN after 
taking Carbamazepine medication. This allele 
however has higher prevalence in Asian and 
especially East Asian populations, including Han 
Chinese, Filipino, Malay, Indian, and Thai [27]. 
This proposes importance of gene loci in the 





This research highlights 9 genes associated with 
the early incidence of SJS and TEN. In this 
study, pathways related gene cluster has also 
been identified and a model to predict SJS and 
TEN early incidences has been developed. 
These findings can be used in assisting and 
supporting clinical prognosis and diagnostic 
biomarkers for further investigation and future 
therapeutic discoveries. It can be suggested that 
SJS and TEN have certain potential link to 
genetic grounds which might be helpful for earlier 
diagnosis of such reactions to avoid more 
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